News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Engelson Erik T.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/13/2023 |
4
| Engelson Erik T. (President and Chief Executive) has filed a Form 4 on Lucira Health, Inc.|
Txns:
| Sold 574,666 shares
@ $1.03, valued at
$591.9k
Sold 60,000 shares
@ $1.09, valued at
$65.4k
Exercised 574,666 options to buy
@ $0.82, valued at
$471.2k
|
|
| 09/19/2022 |
4
| Engelson Erik T. (President and Chief Executive) has filed a Form 4 on Lucira Health, Inc.|
Txns:
| Bought 20,000 shares
@ $1.82, valued at
$36.4k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/26/2021 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
| 02/09/2021 |
4
| Engelson Erik T. (President and Chief Executive) has filed a Form 4 on Lucira Health, Inc.|
Txns:
| Converted 23,282 shares
@ $0
Converted 23,282 preferred shares
@ $0 |
|
| 02/08/2021 |
4
| Engelson Erik T. (President and Chief Executive) has filed a Form 4 on Lucira Health, Inc.|
Txns:
| Granted 173,937 options to buy
@ $17, valued at
$3M
|
|
| 02/04/2021 |
3
| Engelson Erik T. (President and Chief Executive) has filed a Form 3 on Lucira Health, Inc. |
|
|